Case | HBS Case Collection | November 2009

The Explosion of Genetic Testing: Opportunities and Challenges

by Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon


This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay Christensen? Secondly, which business models are likely to be the most successful? Finally, we encourage readers to explore possible future business implications and applications in the area of genetic testing while using a framework of disruptive innovation.

Keywords: Genetics; Health Care and Treatment; Health Testing and Trials; Disruptive Innovation; Business Model; Biotechnology Industry; Health Industry;


Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "The Explosion of Genetic Testing: Opportunities and Challenges." Harvard Business School Case 810-067, November 2009.